Evidence map›Paper›PMID 28594660›Full record

ReviewCurrent opinion in hematology2017

Regulation of the hematopoietic stem cell lifecycle by the endothelial niche.

Pradeep Ramalingam, Michael G Poulos, Jason M Butler

Abstract readReview
In one paragraph

Review in Current opinion in hematology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. 3DACS biomaterials science & engineering · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Closer to Nature: The Role of MSCs in Recreating the Microenvironment of the Hematopoietic Stem Cell Niche in vitro.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Role ofFrontiers in cell and developmental biology · 2021
    Review
  17. Review
  18. Interactions of Hematopoietic Stem Cells with Bone Marrow Niche.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Pradeep RamalingamDepartment of Medicine, Division of Regenerative Medicine, Ansary Stem Cell Institute, Weill Cornell Medical College, New York, USA.
Michael G Poulos
Jason M Butler
Cornell University · US

Funding

Modulating signaling pathways in endothelial cells to abate leukemic progression.R01CA204308 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI BUTLER, JASON MATHEW · 2016 to 2020
$2.0M
Modulating endothelial-specific signaling to enhance functional hematopoiesis.R01HL133021 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI BUTLER, JASON MATHEW · 2016 to 2019
$1.7M
NCI NIH HHS R01 CA204308NHLBI NIH HHS R01 HL133021
6 · The paper itself

Abstract

purpose of reviewHematopoietic stem cells (HSCs) predominantly reside either in direct contact or in close proximity to the vascular endothelium throughout their lifespan. From the moment of HSC embryonic specification from hemogenic endothelium, endothelial cells (ECs) act as a critical cellular-hub that regulates a vast repertoire of biological processes crucial for HSC maintenance throughout its lifespan. In this review, we will discuss recent findings in endothelial niche-mediated regulation of HSC function during development, aging and regenerative conditions. RECENT

findingsStudies employing genetic vascular models have unequivocally confirmed that ECs provide the essential instructive cues for HSC emergence during embryonic development as well as adult HSC maintenance during homeostasis and regeneration. Aging of ECs may impair their ability to maintain HSC function contributing to the development of aging-associated hematopoietic deficiencies. These findings have opened up new avenues to explore the therapeutic application of ECs. ECs can be adapted to serve as an instructive platform to expand bona fide HSCs and also utilized as a cellular therapy to promote regeneration of the hematopoietic system following myelosuppressive and myeloablative injuries. SUMMARY: ECs provide a fertile niche for maintenance of functional HSCs throughout their lifecycle. An improved understanding of the EC-HSC cross-talk will pave the way for development of EC-directed strategies for improving HSC function during aging.

Indexed as

Cell CommunicationStem Cell NicheAgingAnimalsCell DifferentiationCell Self RenewalEndothelial CellsHematopoiesisHematopoietic Stem CellsHumansSignal Transduction

Identifiers

PMID28594660
PMCPMC5554937
OpenAlexW2605621434

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.